Brensocatib, a drug Insmed licensed from AstraZeneca, met the main goal of a Phase 3 test in non-cystic fibrosis bronchiectasis. Insmed plans to seek regulatory approvals in this indication while also continuing to develop the small molecule for other inflammatory disorders.
Butterfly Network recently launched an AI tool that can provide medical practitioners with an accurate B-line count from just a six-second lung ultrasound clip. By automatically counting B-lines in a lung image, the tool helps doctors quickly identify and assess a patient's lung issues at the point of care.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
There’s a lingering misperception among many patients, loved ones, and even healthcare professionals that hospice care is useful only in a patient’s last days or weeks of life.
Thanks to the convergence of cloud technologies, AI, and refined lung data, we are in a new era for those with chronic lung disease. In this new world, lung intelligence provides fast, precision measures of treatment efficacy so new drugs can blaze through the trial pipeline.
A new licensing agreement with Maryland tech company InnoVital Systems marks an important milestone for the Cleveland Clinic’s commercialization arm as the first such deal to come out of its seven-member Healthcare Innovation Alliance. InnoVital Systems, which develops sensors, robotics and electronics for the defense industry, licensed patent rights from Cleveland Clinic Innovations and Maryland […]
We all know that smoking is bad for our health. But how bad is bad? The answer is very bad. It takes a decade off of life. Death rates are about 3 times higher for smokers than nonsmokers. The chance that a young person will live to age 80 is about 70% for nonsmokers but […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.